11.3 Oral & Parenteral Routes, Sites & Equipment
Key Takeaways
- Task 3.06.5 covers oral administration: verify swallow ability, correct form (tablet, capsule, liquid, buccal, sublingual), and do not crush extended-release or enteric-coated products without an order.
- Tasks 3.06.6–3.06.7 require selecting needle gauge/length by route and site and administering SQ, IM, ID, and inhalation correctly (IV is excluded from this CMAC parenteral task set).
- Classic angles: ID ~10–15°, SQ ~45° (or 90° with short needle/adequate tissue per technique), IM 90°.
- Task 3.06.9: dispose of needles and syringes immediately in a puncture-resistant sharps container—never recap using a two-handed scoop of a contaminated needle as routine practice.
- Match volume and viscosity to site: small ID volumes, limited SQ volumes, larger IM volumes only in appropriate muscles.
Routes Overview (What the Blueprint Tests)
After rights and math, CMAC tests how you give the drug. Blueprint cluster:
- 3.06.5 Oral medications
- 3.06.6 Sites and equipment (needle length and gauge) for parenteral meds excluding IV
- 3.06.7 Parenteral methods: SQ, IM, ID, and inhalation
- 3.06.9 Dispose of parenteral equipment correctly
Parenteral here means routes that bypass the GI tract via injection or inhalation devices as listed—not starting peripheral IVs (outside this task wording).
3.06.5 — Administering Oral Medications
Forms and Special Rules
| Form | Key administration points |
|---|---|
| Tablet / capsule | Sitting upright; full glass of water unless NPO or fluid-restricted order differs; do not leave at bedside unattended if policy requires observed dose |
| Scored tablet | Split only if scored and policy allows; clean pill cutter |
| Enteric-coated / extended-release / SR / XR / EC | Do not crush or chew unless order explicitly allows a different form |
| Sublingual (SL) | Under tongue; do not swallow until dissolved; no water immediately if it washes drug away |
| Buccal | Between gum and cheek |
| Liquid / suspension | Shake if directed; measure with oral syringe/cup; never use parenteral syringe with needle for oral dosing in a way that risks wrong-route injection—use oral-tipped devices when available |
| Lozenge | Dissolve; do not chew if labeled otherwise |
Oral Administration Steps
- Apply seven rights; check swallow status, NPO status, and nausea.
- Prepare dose; don gloves if handling the tablet is required by policy or patient contact risk.
- Position patient upright (Fowler’s when possible).
- Offer water; observe the patient take the medication.
- Recheck that the dose was swallowed (not cheeked) when risk warrants.
- Document; monitor for adverse effects as indicated.
Do not crush list mentality: If crushing is needed for a feeding tube or dysphagia, obtain the correct order/formulation—many long-acting cardiac and pain meds become dangerous if crushed.
3.06.6–3.06.7 — Parenteral Sites, Needles, and Techniques
Needle Basics
- Gauge: larger number = thinner needle (25 G is thinner than 21 G).
- Length: must reach the intended tissue without hitting bone or depositing IM drug into fat unintentionally.
- Syringe: choose the smallest syringe that holds the dose for accuracy (e.g., 1 mL tuberculin for ID).
Site / Route Equipment Table (Classic Teaching Ranges)
Ranges vary slightly by textbook and body habitus—know the typical ambulatory care set below and adjust per facility protocol and patient size.
| Route | Common sites | Typical needle gauge | Typical needle length | Angle | Usual volume guidance |
|---|---|---|---|---|---|
| ID | Inner forearm; upper back | 25–27 G | ⅜–⅝ in | 10–15° | ~0.01–0.1 mL (e.g., TB skin test 0.1 mL) |
| SQ | Upper arm (posterior), abdomen (≥2 in from umbilicus), anterior thigh, upper back | 25–31 G | ⅜–⅝ in (often ½ in) | 45° standard; 90° with short needle/adequate pinch per technique | Typically ≤1 mL (often 0.5–1 mL) |
| IM — deltoid | Acromion process landmark; inject 2–3 fingerbreadths below in midline of muscle | 22–25 G | 1–1½ in adults (⅝–1 in smaller adults/children per size) | 90° | Often ≤1–2 mL (vaccines commonly 0.5–1 mL) |
| IM — vastus lateralis | Middle third of anterolateral thigh | 22–25 G | 1–1½ in (age/size dependent) | 90° | Preferred IM site for infants; larger volumes than deltoid in many protocols |
| IM — ventrogluteal | Side-lying preferred; landmarks: greater trochanter, anterior superior iliac spine, iliac crest | 20–25 G | 1–1½ in | 90° | Preferred large-volume IM in many adults; safer than dorsogluteal for sciatic risk |
| IM — dorsogluteal | Historically used; higher sciatic nerve injury risk | — | — | 90° if used | Many modern protocols prefer ventrogluteal over dorsogluteal |
| Inhalation | Mouthpiece/mask per device | N/A | N/A | N/A | Metered dose, DPI, nebulizer per order |
Intradermal (ID) Technique
- Select site (usually volar forearm for TB testing), cleanse, allow dry.
- Stretch skin; insert bevel up at 10–15° until bevel is covered.
- Inject slowly to raise a small wheal/bleb.
- Do not massage TB tests; instruct patient on reading window (e.g., 48–72 hours for TST).
- Document lot, site, and time as required.
If no wheal appears, the dose may have gone SQ—follow protocol for repeating (especially TB testing).
Subcutaneous (SQ) Technique
- Rotate sites for repeated injections (insulin, heparin products).
- Pinch skin fold as taught for needle length/angle.
- Insert quickly at 45° or 90° per technique; inject steadily.
- For heparin/enoxaparin-type products, follow product rules (often no aspiration; sometimes do not rub).
- Activate safety needle; sharps disposal immediately.
Abdomen often preferred for consistent insulin absorption; avoid scarred, inflamed, or lipohypertrophic areas.
Intramuscular (IM) Technique
- Landmark carefully—never “eyeball” the buttock without anatomy.
- Cleanse; insert at 90° with a dart-like motion.
- Aspiration policies vary by medication and current guidance (many vaccines: no aspiration); follow current facility protocol and product instructions.
- Inject slowly; withdraw; apply gentle pressure; do not massage depot medications if contraindicated.
- Use Z-track for irritating IM medications when ordered/taught: pull skin laterally, inject, withdraw, release skin to seal path.
Deltoid Landmark (Vaccines & Many Adult IM Meds)
- Expose shoulder; find acromion process.
- Place 2–3 fingers below acromion; inject into the dense muscle below, above the axillary fold—avoid too high (shoulder injury) or too low (axilla).
- Seat patient; support arm.
Inhalation Technique (Task Includes “by inhalation”)
| Device | MA teaching / assist points |
|---|---|
| MDI (metered-dose inhaler) | Shake if required; spacer often improves delivery; slow deep inhale with actuation; hold breath ~10 seconds when able; wait between puffs if ordered |
| DPI (dry powder) | Load dose per device; forceful deep inhale; do not exhale into device |
| Nebulizer | Assemble cup/tubing; correct med volume; upright position; breathe normally until mist finishes; clean equipment per infection control |
| ICS inhalers | Rinse mouth after steroid inhalers to reduce thrush |
For clinic-administered nebulizer treatments, verify order, patient ID, pre/post assessment per protocol (e.g., peak flow/SpO₂ if used), and document.
Volume and Site Decision Logic
| Situation | Prefer |
|---|---|
| Adult influenza or many IM vaccines 0.5 mL | Deltoid if muscle adequate |
| Infant IM immunization | Vastus lateralis |
| Larger-volume irritating IM in adult | Ventrogluteal (when appropriate) |
| Insulin, many biologics SQ, heparin SQ | SQ sites with rotation |
| TB skin test | ID forearm |
If the ordered volume exceeds site capacity, clarify—do not split randomly without an order.
3.06.9 — Dispose of Parenteral Equipment Correctly
Sharps Safety Non-Negotiables
- Immediately after injection, activate engineered safety device if present, pointing away from you and the patient.
- Place needle/syringe unit into a puncture-resistant, labeled sharps container at the point of use.
- Do not bend, break, or remove needles from syringes by hand routinely.
- Do not recap contaminated needles using two hands; if recapping is unavoidable in a rare protocol situation, use a one-handed scoop—prefer safety devices that eliminate recapping.
- Replace sharps containers at the fill line (often ¾ full)—never overstuff.
- Sharps containers go in regulated medical waste streams per OSHA/facility rules—not regular trash.
- Report needlestick injuries immediately (wash, notify, occupational health protocol).
Other Parenteral Waste
- Empty vials and ampoules: sharps or pharma waste per policy (ampoule glass is sharps).
- Controlled-substance residual: waste with witness and documentation when required (Section 11.1).
- Bloody gauze: biohazard bag if saturated per policy; sharps never in biohazard bags soft-sided only.
End-to-End Parenteral Checklist
- Order + seven rights + calculation.
- Hand hygiene; assemble syringe/needle/alcohol/gloves/band-aid/sharps container.
- Draw up using aseptic vial technique (alcohol hub, correct air injection for vials as taught, filter needle for ampoules if required).
- Change to appropriate administration needle if a blunt fill needle was used.
- Position patient; landmark; cleanse; inject at correct angle.
- Safety engage; sharps container immediately.
- Document med, dose, route, site, time, lot/expiration when required, tolerance.
- Observe for adverse reaction per protocol (especially first-dose antibiotics and vaccines—Section 11.4).
CMAC Exam Traps for Tasks 3.06.5–3.06.7 & 3.06.9
- Crushing an XR tablet for convenience.
- Using a 1½-inch needle for a thin adult deltoid without assessing (or using a tiny needle that deposits IM drug in fat).
- ID injection at 90° with no wheal for a TB test.
- Choosing dorsogluteal as the “always best” adult IM site.
- Recapping a used needle with two hands and carrying it across the clinic.
- Giving oral meds to a semi-conscious patient lying flat.
- Massaging after ID TB testing.
Memory anchors: oral upright + don’t crush XR/EC; ID 10–15° wheal; SQ 45/90; IM 90° with landmarks; thinner = higher gauge; sharps in at once.
Which needle angle is appropriate for a standard intradermal TB skin test?
An adult is to receive a 0.5 mL intramuscular influenza vaccine in the deltoid. Which equipment choice is most appropriate among typical teaching ranges?
Which oral medication action is unsafe?
Immediately after giving an intramuscular injection with a safety-engineered syringe, what is the correct disposal step?